PLSE Pulse Biosciences, Inc.

NASDAQ
$58.17

Pulse Biosciences, Inc. (PLSE) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.35 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +2.3% since its last earnings release on November 5, 2026.

Pulse Biosciences Beat Consensus Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
4th Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.35)
Rev est $750K
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $56.00

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Pulse Biosciences, Inc.

Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the potential to improve the quality of life for patients.

Sector

Healthcare

Industry

Medical Instruments/Supply

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.